[{"address1": "2430 North Halsted Street", "city": "Chicago", "state": "IL", "zip": "60614", "country": "United States", "phone": "847 673 1700", "fax": "847 556 6411", "website": "https://www.exicuretx.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Exicure, Inc. does not have significant operations. previously, the company focused on developing of nucleic acid therapies targeting ribonucleic acid against validated targets. Exicure, Inc. was founded in 2011 and is headquartered in Chicago, Illinois.", "companyOfficers": [{"maxAge": 1, "name": "Mr. Paul  Kang", "age": 61, "title": "CEO & Director", "yearBorn": 1962, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Jiyoung  Hwang", "age": 48, "title": "CFO & Director", "yearBorn": 1975, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Joshua  Miller", "age": 47, "title": "Chief Accounting Officer", "yearBorn": 1976, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Bart  Anderson", "title": "Senior Director of R&D", "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 10, "boardRisk": 10, "compensationRisk": 10, "shareHolderRightsRisk": 7, "overallRisk": 10, "governanceEpochDate": 1717200000, "maxAge": 86400, "priceHint": 4, "previousClose": 0.4735, "open": 0.42, "dayLow": 0.3719, "dayHigh": 0.438, "regularMarketPreviousClose": 0.4735, "regularMarketOpen": 0.42, "regularMarketDayLow": 0.3719, "regularMarketDayHigh": 0.438, "trailingPE": 0.18683964, "forwardPE": -0.5144156, "volume": 198550, "regularMarketVolume": 198550, "averageVolume": 296895, "averageVolume10days": 1719400, "averageDailyVolume10Day": 1719400, "marketCap": 3426720, "fiftyTwoWeekLow": 0.3, "fiftyTwoWeekHigh": 1.5, "fiftyDayAverage": 0.514, "twoHundredDayAverage": 0.61479, "currency": "USD", "enterpriseValue": 8649720, "floatShares": 7809651, "sharesOutstanding": 8651150, "sharesShort": 126462, "sharesShortPriorMonth": 151664, "sharesShortPreviousMonthDate": 1713139200, "dateShortInterest": 1715731200, "sharesPercentSharesOut": 0.0146, "heldPercentInsiders": 0.45023, "heldPercentInstitutions": 0.10305, "shortRatio": 3.59, "shortPercentOfFloat": 0.0168, "impliedSharesOutstanding": 8651010, "bookValue": 0.35, "priceToBook": 1.1317143, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1703980800, "netIncomeToCommon": -16914000, "trailingEps": 2.12, "forwardEps": -0.77, "lastSplitFactor": "1:30", "lastSplitDate": 1656547200, "enterpriseToEbitda": -0.643, "52WeekChange": -0.61176467, "SandP52WeekChange": 0.23232913, "exchange": "NCM", "quoteType": "EQUITY", "symbol": "XCUR", "underlyingSymbol": "XCUR", "shortName": "Exicure, Inc.", "longName": "Exicure, Inc.", "firstTradeDateEpochUtc": 1526995800, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "ee4bcb27-f318-38c7-8572-459785e7d845", "messageBoardId": "finmb_82271676", "gmtOffSetMilliseconds": -14400000, "currentPrice": 0.3961, "recommendationMean": 3.0, "recommendationKey": "hold", "totalCash": 816000, "totalCashPerShare": 0.094, "ebitda": -13442000, "totalDebt": 6039000, "quickRatio": 0.331, "currentRatio": 0.806, "debtToEquity": 199.241, "returnOnAssets": -0.50404, "returnOnEquity": -1.88425, "freeCashflow": -5746500, "operatingCashflow": -10357000, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2024-06-10"}]